Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Gelrud, Andres, Digenio, Andres, Alexander, Veronica J., Williams, Karren R., Hsieh, Andrew, Gouni-Berthold, Ionna, Bruckert, Eric, Stroes, Erik, Geary, Richard, Hughes, Steven, Tsimikas, Sotirios and Gaudet, Daniel (2018). TREATMENT WITH VOLANESORSEN (VLN) REDUCED TRIGLYCERIDES AND PANCREATITIS IN PATIENTS WITH FCS AND SHTG VS PLACEBO: RESULTS OF THE APPROACH AND COMPASS STUDIES. Atheroscler. Suppl., 32. S. 157 - 158. CLARE: ELSEVIER IRELAND LTD. ISSN 1878-5050

Gouni-Berthold, Ioanna, Alexander, Veronica J., Yang, Qingqing, Hurh, Eunju, Steinhagen-Thiessen, Elisabeth, Moriarty, Patrick M., Hughes, Stephen G., Gaudet, Daniel, Hegele, Robert A., O'Dea, Louis St L., Stroes, Erik S. G., Tsimikas, Sotirios and Witztum, Joseph L. (2021). Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol., 9 (5). S. 264 - 276. NEW YORK: ELSEVIER SCIENCE INC. ISSN 2213-8595

Tsimikas, Sotirios, Karwatowska-Prokopczuk, Ewa, Gouni-Berthold, Ioanna, Tardif, Jean-Claude, Baum, Seth J., Steinhagen-Thiessen, Elizabeth, Shapiro, Michael D., Stroes, Erik S., Moriarty, Patrick M., Nordestgaard, Borge G., Xia, Shuting, Guerriero, Jonathan, Viney, Nicholas J., O'Dea, Louis and Witztum, Joseph L. (2020). Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. N. Engl. J. Med., 382 (3). S. 244 - 256. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Tsimikas, Sotirios, Karwatowska-Prokopczuk, Ewa, Gouni-Berthold, Loanna, Tardif, Jean-Claude, Baum, Seth J., Steinhagen-Thiessen, Elisabeth, Shapiro, Michael D., Stroes, Erik D., Moriarty, Patrick M., Nordestgaard, Borge G., Guerriero, Jonathan, Viney, Nicholas J., O'Dea, Louis and Witztum, Joseph L. (2018). Safety and Efficacy of AKCEA-APO(a)-1 to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose -Ranging Trial. Circulation, 138 (25). S. E755 - 2. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1524-4539

This list was generated on Thu Apr 25 03:08:46 2024 CEST.